These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8706771)

  • 21. Plasma asparaginase activity, asparagine concentration, and toxicity after administration of Erwinia asparaginase in children and young adults with acute lymphoblastic leukemia: Phase I/II clinical trial in Japan.
    Ogawa C; Taguchi F; Goto H; Koh K; Tomizawa D; Ohara A; Manabe A
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28244643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations.
    Ballerini A; Moro F; Nerini IF; Marzo CM; Di Clemente A; Ferrari M; D'Incalci M; Biondi A; Colombini A; Conter V; Porcu L; Cervo L; Rizzari C; Zucchetti M
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1267-1271. PubMed ID: 28424964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia.
    Henriksen LT; Nersting J; Raja RA; Frandsen TL; Rosthøj S; Schrøder H; Albertsen BK;
    Br J Haematol; 2014 Jul; 166(2):213-20. PubMed ID: 24702187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new chemotherapeutic agent: L-asparaginase entrapped in red blood cells.
    Sinauridze EI; Vitvitsky VM; Pichugin AV; Zhabotinsky AM; Ataullakhanov FI
    Adv Exp Med Biol; 1992; 326():203-6. PubMed ID: 1295308
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic alternatives to native L-asparaginase in the treatment of adult acute lymphoblastic leukemia].
    Thomas X; Cannas G; Chelghoum Y; Gougounon A
    Bull Cancer; 2010 Sep; 97(9):1105-17. PubMed ID: 20693115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyethylene glycol-L-asparaginase and L-asparaginase studies in rabbits.
    Ho DH; Wang CY; Lin JR; Brown N; Newman RA; Krakoff IH
    Drug Metab Dispos; 1988; 16(1):27-9. PubMed ID: 2894951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid asparagine concentrations after Escherichia coli asparaginase in children with acute lymphoblastic leukemia.
    Woo MH; Hak LJ; Storm MC; Gajjar AJ; Sandlund JT; Harrison PL; Wang B; Pui CH; Relling MV
    J Clin Oncol; 1999 May; 17(5):1568-73. PubMed ID: 10334545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of recombinant asparaginase in children with acute lymphoblastic leukemia.
    Völler S; Pichlmeier U; Zens A; Hempel G
    Cancer Chemother Pharmacol; 2018 Feb; 81(2):305-314. PubMed ID: 29204688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent.
    Ghasemi A; Asad S; Kabiri M; Dabirmanesh B
    Appl Microbiol Biotechnol; 2017 Oct; 101(19):7227-7238. PubMed ID: 28801829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors.
    Taylor CW; Dorr RT; Fanta P; Hersh EM; Salmon SE
    Cancer Chemother Pharmacol; 2001; 47(1):83-8. PubMed ID: 11221967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacology of polyethylene glycol-L-asparaginase.
    Ho DH; Brown NS; Yen A; Holmes R; Keating M; Abuchowski A; Newman RA; Krakoff IH
    Drug Metab Dispos; 1986; 14(3):349-52. PubMed ID: 2872037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acrylic microspheres in vivo VI: antitumor effect of microparticles with immobilized L-asparaginase against 6C3HED lymphoma.
    Edman P; Sjöholm I
    J Pharm Sci; 1983 Jun; 72(6):654-8. PubMed ID: 6875826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug monitoring of low-dose PEG-asparaginase (Oncaspar) in children with relapsed acute lymphoblastic leukaemia.
    Vieira Pinheiro JP; Müller HJ; Schwabe D; Gunkel M; Casimiro da Palma J; Henze G; von Schütz V; Winkelhorst M; Würthwein G; Boos J
    Br J Haematol; 2001 Apr; 113(1):115-9. PubMed ID: 11328290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring asparaginase activity in middle-income countries.
    Cecconello DK; Werlang ICR; Alegretti AP; Hahn MC; de Magalhães MR; Battistel AP; Zenatti PP; Yunes JA; Cabreira-Cagliari C; Rechenmacher C; Goldani MZ; Daudt LE; Michalowski MB
    Lancet Oncol; 2018 Sep; 19(9):1149-1150. PubMed ID: 30078698
    [No Abstract]   [Full Text] [Related]  

  • 35. Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols.
    Müller HJ; Löning L; Horn A; Schwabe D; Gunkel M; Schrappe M; von Schütz V; Henze G; Casimiro da Palma J; Ritter J; Pinheiro JP; Winkelhorst M; Boos J
    Br J Haematol; 2000 Aug; 110(2):379-84. PubMed ID: 10971395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of immobilized L-asparaginase in acrylic microparticles in an extracorporeal hollow-fiber dialyzer.
    Edman P; Nylén U; Sjöholm I
    J Pharmacol Exp Ther; 1983 Apr; 225(1):164-7. PubMed ID: 6834269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Research on the pharmacokinetics and pharmacodynamics of L-asparaginase during its treatment of childhood acute lymphoblastic leukemia].
    Chen FX; Cui YQ; Wu ZL; Ye TZ; Lai YH; Zou YW; Lu CY; Guan JM; Wei FG; Zhang H
    Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):100-2. PubMed ID: 15921627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of Escherichia coli-L-asparaginase polyethylene glycol adduct.
    Park YK; Abuchowski A; Davis S; Davis F
    Anticancer Res; 1981; 1(6):373-6. PubMed ID: 7046623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma.
    Bachet JB; Gay F; Maréchal R; Galais MP; Adenis A; MsC DS; Cros J; Demetter P; Svrcek M; Bardier-Dupas A; Emile JF; Hammel P; Ebenezer C; Berlier W; Godfrin Y; André T
    Pancreas; 2015 Oct; 44(7):1141-7. PubMed ID: 26355551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system.
    Albertsen BK; Schrøder H; Ingerslev J; Jakobsen P; Avramis VI; Müller HJ; Carlsen NT; Schmiegelow K
    Br J Haematol; 2001 Dec; 115(4):983-90. PubMed ID: 11843837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.